Cholesterol absorption inhibitor ezetimibe: Risk-benefits and role in treating dyslipidemias

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

本文言語	英語
ページ（範囲）	465-481
ページ数	17
ジャーナル	Contemporary Endocrinology
巻	1
DOI	https://doi.org/10.1007/978-1-60761-424-1_28
出版ステータス	出版済み - 2015

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

@article{359eee4f63744352ace3035aad4bcbc4,

title = "Cholesterol absorption inhibitor ezetimibe: Risk-benefits and role in treating dyslipidemias",

author = "Shizuya Yamashita and Daisaku Masuda and Akifumi Matsuyama",

year = "2015",

doi = "10.1007/978-1-60761-424-1\_28",

language = "English",

volume = "1",

pages = "465--481",

journal = "Contemporary Endocrinology",

issn = "0196-8653",

publisher = "Humana Press Inc.",

}

TY - JOUR

T1 - Cholesterol absorption inhibitor ezetimibe

T2 - Risk-benefits and role in treating dyslipidemias

AU - Yamashita, Shizuya

AU - Masuda, Daisaku

AU - Matsuyama, Akifumi

PY - 2015

Y1 - 2015

UR - https://www.scopus.com/pages/publications/84976588043

UR - https://www.scopus.com/pages/publications/84976588043#tab=citedBy

U2 - 10.1007/978-1-60761-424-1_28

DO - 10.1007/978-1-60761-424-1_28

M3 - Article

AN - SCOPUS:84976588043

SN - 0196-8653

VL - 1

SP - 465

EP - 481

JO - Contemporary Endocrinology

JF - Contemporary Endocrinology

ER -